A new generation artificial heart prosthetic from the company CARMAT has just been successfully implanted in a 39-year old US patient for the very first time! Surgeons at Duke University have just been able to implant a new-generation artificial heart prosthetic in a man that was experiencing heart failure.
Artificial Heart Implant
According to GoodNewsNetwork, this is the first time the new CARMAT total artificial heart has been successfully implanted in any North American hospital.
CARMAT is a french company, and its developed artificial heart has been approved for use and sale around Europe.
It is worth noting that it is not the first time a patient has received an artificial heart transplant in the US, as the first-ever patient to have it was Dr. Barney Clark, who received the transplant in the University of Utah Hospital on December 1982, as per the university's blog.
However, Clark died after more than 100 days of having the operation.
Some time last year, the company had been able to receive US FDA approval in order to start studies and enroll 10 patients with end-stage biventricular heart failure and would offer a life-saving bridge before the transplant. This is for people who are suffering and on the list waiting for a heart donor. There have been a lot of groundbreaking medical technologies as of late like neural implants which helped a paralyzed man speak again.
Transplant Successful on Matthew Moore
Transplant surgeon and also the principal investigator of the device study over at Duke, Dr. Carmelo Milano noted that they are encouraged that their patient is now doing so well after the recent procedure. It was noted that as they evaluate the device, they are both hopeful and excited that patients who have few to no options otherwise could finally have a lifeline.
Matthew Moore, the North Carolina patient, is only 39-years-old and was referred to Duke back in June 2021 after a sudden and unexpected diagnosis of heart failure. Moore, his wife Rachel, and their newly adopted two-year-old foster son Marshal have just arrived at Duke expecting to go through just heart bypass surgery.
Transplant Became too Risky
Moore's condition then quickly deteriorated. Traditional options,which included transplant, had also become too risky. Duke, in the meanwhile, was among just three different transplant centers in the US that were selected to join the device study. The procedure team reportedly received specialized training in order to prepare for the implant surgery.
Matthew's wife Rachel, a nurse, noted that both of them were grateful that they've had the opportunity to participate in something that has a significant potential to have a direct impact on a number of lives. Rachel noted that they are just taking everything day-by-day and that they hope everything will continue to progress well. Aside from this technology, AI has also been used around lately in helping researchers sense early signs of dementia.
Read Also: Parkinson's Disease Could Be Halted by Dancing to Music
Artificial Heart Device 'Aeson'
The artificial heart device is called "Aeson" and is an implantable prosthetic which includes biological valves that come from bovine tissue and operates using an external power supply. If the device finally receives FDA approval, it would then give hope for transplant patients requiring heart assistance to pump blood through both chambers. The current LVAD or left-ventricular assist device technology can only support one chamber, as seen on StanfordHealthcare.
Schroder, a transplant surgeon who reportedly led the implant procedure noted that due to the shortage of donor hearts, most patients end up dying while still waiting for a heart transplant. It was noted that they are helpful for new options to be able to help patients just like Mr. Moore who has a devastating disease and also cannot otherwise be considered to receive a transplant.
Related Article: The Dangers and Side Effects of Anabolic Steroids
This article is owned by tech Times
Written by Urian B.
